digraph { 
 node [ fontname="DejaVu Sans" ] ; 
	node2 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node5 -> node6 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node7 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node8 -> node9 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node12 -> node13 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node15 -> node16 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node18 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node19 -> node10 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node20 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node21 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node22 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node25 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node32 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node36 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node8 -> node40 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node41 -> node42 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node43 -> node44 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node46 -> node47 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node50 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node55 -> node56 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node57 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node60 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node62 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node64 -> node65 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node66 -> node67 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node69 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node0 -> node26 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node13 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node71 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node72 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node73 -> node74 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node75 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node76 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node77 -> node78 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node69 -> node79 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node80 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node81 -> node82 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node83 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node84 -> node30 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node2 -> node85 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node86 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node66 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node84 -> node87 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node69 -> node88 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node55 -> node91 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node46 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node90 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node94 -> node60 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node95 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node96 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node100 -> node63 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node101 -> node102 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node104 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node105 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node34 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node106 -> node107 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node108 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node109 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node12 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node114 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node15 -> node115 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node116 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node43 -> node117 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node118 -> node119 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node120 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node121 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node122 -> node34 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node15 -> node123 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node124 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node125 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node126 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node87 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node64 -> node31 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node127 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node128 -> node129 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node98 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node119 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node8 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node133 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node118 -> node134 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node98 -> node120 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node10 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node138 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node12 -> node139 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node140 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node8 -> node141 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node142 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node140 -> node144 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node122 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node113 -> node147 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node16 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node88 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node150 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node43 -> node151 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node1 -> node99 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node152 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node110 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node93 -> node154 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node106 -> node116 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node81 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node48 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node5 -> node59 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node75 -> node158 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node160 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node7 -> node14 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node84 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node72 -> node161 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node162 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node156 -> node165 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node65 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node166 -> node127 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node101 -> node167 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node47 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node5 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node136 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node113 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node168 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node92 -> node50 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node155 -> node169 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node0 -> node133 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node170 -> node136 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node171 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node122 -> node173 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node9 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node0 -> node174 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node43 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node176 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node115 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node52 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node66 -> node177 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node178 -> node126 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node179 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node1 -> node97 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node33 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node181 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node167 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node182 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node105 -> node137 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node21 -> node183 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node39 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node64 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node30 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node52 -> node186 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node18 -> node58 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node106 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node157 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node112 -> node190 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node63 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node128 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node43 -> node192 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node91 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node7 -> node193 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node72 -> node195 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node1 -> node109 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node51 -> node24 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node12 -> node184 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node81 -> node196 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node197 -> node145 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node169 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node173 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node101 -> node150 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node71 -> node138 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node42 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node117 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node137 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node92 -> node199 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node192 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node200 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node202 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node35 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node111 -> node203 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node0 -> node149 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node64 -> node95 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node170 -> node68 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node204 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node15 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node92 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node132 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node129 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node205 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node105 -> node206 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node181 -> node207 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node197 -> node209 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node112 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node197 -> node188 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node94 -> node211 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node185 -> node212 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node41 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node97 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node166 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node64 -> node38 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node213 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node214 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node84 -> node22 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node43 -> node53 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node70 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node100 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node197 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node140 -> node215 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node1 -> node216 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node194 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node51 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node52 -> node217 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node218 -> node35 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node49 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node53 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node191 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node28 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node89 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node0 -> node89 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node19 -> node221 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node58 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node189 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node64 -> node70 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node194 -> node157 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node196 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node113 -> node213 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node222 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node4 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node135 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node141 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node174 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node223 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node148 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node94 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node55 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node208 -> node172 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node12 -> node225 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node131 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node62 -> node135 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node75 -> node226 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node98 -> node227 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node31 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node78 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node118 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node182 -> node83 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node156 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node101 -> node229 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node188 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node175 -> node114 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node101 -> node90 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node12 -> node33 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node195 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node218 -> node27 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node48 -> node222 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node12 -> node131 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node64 -> node189 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node25 -> node230 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node231 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node179 -> node108 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node166 -> node232 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node175 -> node76 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node175 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node84 -> node233 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node121 -> node234 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node194 -> node235 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node103 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node21 -> node228 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node73 -> node198 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node61 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node0 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node164 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node146 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node224 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node163 -> node103 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node77 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node224 -> node168 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node220 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node187 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node139 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node181 -> node61 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node111 -> node202 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node93 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node49 -> node54 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node142 -> node200 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node96 -> node237 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node8 -> node152 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node185 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node12 -> node159 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node210 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node49 -> node11 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node14 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node208 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node175 -> node238 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node11 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node77 -> node239 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node208 -> node240 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node24 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node186 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node101 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node1 -> node39 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node219 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node122 -> node241 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node102 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node143 -> node242 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node96 -> node214 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node43 -> node236 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node64 -> node243 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node12 -> node153 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node29 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node156 -> node220 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node2 -> node125 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node208 -> node36 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node185 -> node57 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node143 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node25 -> node171 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node43 -> node160 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node45 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node164 -> node244 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node164 -> node176 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node201 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node27 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node54 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node37 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node198 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node155 -> node245 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node52 -> node124 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node144 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node121 -> node132 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node93 -> node191 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node170 -> node210 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node111 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node142 -> node246 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node163 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node68 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node172 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node170 -> node4 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node112 -> node180 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node179 -> node247 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node219 -> node204 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node73 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node62 -> node248 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node110 -> node17 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node1 -> node104 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node170 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node224 -> node231 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node184 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node121 -> node37 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node62 -> node187 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node56 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node182 -> node249 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node12 -> node80 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node148 -> node162 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node20 -> node201 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node20 -> node250 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node178 -> node251 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node151 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node59 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node86 -> node45 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node1 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node155 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node17 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node32 -> node130 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node51 -> node252 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node143 -> node29 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node149 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node71 -> node253 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node159 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node0 -> node254 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node228 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node218 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node180 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node26 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node100 -> node205 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node99 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node145 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node8 -> node223 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node153 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node148 -> node255 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node128 -> node256 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node158 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node236 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node38 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node218 -> node257 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:url</font> > ] ;
	node62 -> node28 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node19 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node130 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node175 -> node146 [ color=BLACK, label=< <font point-size='10' color='#336633'>schema:study</font> > ] ;
	node67 -> node23 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
	node178 -> node3 [ color=BLACK, label=< <font point-size='10' color='#336633'>rdf:type</font> > ] ;
# https://drugcentral.org/drugcard/26 node0
node0 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>fluorouracil</B></td></tr><tr><td href='https://drugcentral.org/drugcard/26' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/26</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL185&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/1282 node1
node1 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>gefitinib</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1282' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1282</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://pubmed.ncbi.nlm.nih.gov/22037378&quot;</td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/2179 node2
node2 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>pioglitazone</B></td></tr><tr><td href='https://drugcentral.org/drugcard/2179' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/2179</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL595&quot;</td></tr></table> > ] 
# https://schema.org/Drug node3
node3 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Drug</B></td></tr><tr><td href='https://schema.org/Drug' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://schema.org/Drug</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00017043 node4
node4 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase II Study of Epothilone Analog BMS-247550 in Patients With Metastatic Gastric Adenocarcinoma Previously Treated With a Taxane</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00017043' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00017043</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Esophageal Cancer&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/960 node5
node5 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>doxorubicin</B></td></tr><tr><td href='https://drugcentral.org/drugcard/960' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/960</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53463&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D004317 node6
node6 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D004317</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D004317' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D004317</font></td></tr></table> > ] 
# https://drugcentral.org/drugcard/435 node7
node7 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>bupropion</B></td></tr><tr><td href='https://drugcentral.org/drugcard/435' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/435</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201735&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/939 node8
node8 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>docetaxel</B></td></tr><tr><td href='https://drugcentral.org/drugcard/939' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/939</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545252&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015886 node9
node9 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Docetaxel (Taxotere) and 5-Fluorouracil As Second- Or Third-Line Chemotherapy In Women With Metastatic Breast Cancer</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015886' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015886</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Breast Cancer&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00017030 node10
node10 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase II Study of ET-743 Given as a Three Hour Intravenous Infusion in Patients With Advanced and/or Metastatic Soft Tissue Sarcoma Previously Treated With Chemotherapy</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00017030' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00017030</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Sarcoma&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00010010 node11
node11 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase II Study of the Combination of Exemestane and Goserelin in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00010010' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00010010</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Breast Cancer&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/4392 node12
node12 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>cisplatin</B></td></tr><tr><td href='https://drugcentral.org/drugcard/4392' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/4392</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00012220 node13
node13 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Randomized Phase II Study Of Gemcitabine/Cisplatin, Gemcitabine/Docetaxel, Gemcitabine/Irinotecan, Or Fixed Dose Rate Infusion Gemcitabine In Patients With Metastic Pancreatic Cancer</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00012220' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00012220</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Pancreatic Cancer&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00018187 node14
node14 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Combinations of Pharmacologic Smoking Cessation Treatments</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00018187' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00018187</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Smoking&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/2068 node15
node15 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>paroxetine</B></td></tr><tr><td href='https://drugcentral.org/drugcard/2068' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/2068</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200609&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00018759 node16
node16 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Treatment Effects on Platelet Calcium in Hypertensive and Depressed Patients</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00018759' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00018759</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Depression&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015704 node17
node17 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>An Open-Label, Pilot Study Utilizing CD4 T-Cell Counts Lower Than 350 Cells/mm3 as the Threshold for Restarting Therapy With Potent Antiretroviral Therapy With or Without Interleukin-2 to Determine the Effect of Pulse Therapy on the Characteristics of Treatment Interruptions</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015704' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015704</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;HIV Infections&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/4119 node18
node18 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>romidepsin</B></td></tr><tr><td href='https://drugcentral.org/drugcard/4119' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/4119</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022393s013lbl.pdf&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/4633 node19
node19 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>trabectedin</B></td></tr><tr><td href='https://drugcentral.org/drugcard/4633' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/4633</font></td></tr></table> > ] 
# https://drugcentral.org/drugcard/1277 node20
node20 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>ganciclovir</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1277' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1277</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL182&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/2405 node21
node21 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>rosiglitazone</B></td></tr><tr><td href='https://drugcentral.org/drugcard/2405' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/2405</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL121&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00010023 node22
node22 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase I Study of Oral Fluoropyrimidine Capecitabine (Xeloda Roche) Combined With Intravenous Cisplatin in Patients With Advanced Cancer of the Digestive System</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00010023' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00010023</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Cancer&quot;</td></tr></table> > ] 
# https://schema.org/MedicalStudy node23
node23 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>MedicalStudy</B></td></tr><tr><td href='https://schema.org/MedicalStudy' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://schema.org/MedicalStudy</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00016666 node24
node24 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Treatment of Winter Depression With Pharmacological Suppression of Melatonin Secretion</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00016666' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00016666</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Seasonal Affective Disorder&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/4956 node25
node25 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>bevacizumab</B></td></tr><tr><td href='https://drugcentral.org/drugcard/4956' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/4956</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125085s305lbl.pdf&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00010088 node26
node26 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Study Of Gemcitabine, Leukovorin, And Fluorouracil Used To Treat Locally Advanced And Metastatic Pancreatic And Biliary Adenocarcinomas</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00010088' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00010088</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Extrahepatic Bile Duct Cancer&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00014599 node27
node27 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase II Clinical Trial On Taxol As Single Agent In Locally Advanced And/Or Metastatic Or Recurrent Vulva Cancer Not Amenable For Surgery And/Or Radiotherapy</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00014599' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00014599</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Vulvar Cancer&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00017329 node28
node28 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase II Trial of PS341 (NSC 681239) in Patients With Advanced Renal Cell Carcinoma</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00017329' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00017329</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Kidney Cancer&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00018148 node29
node29 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00018148' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00018148</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Smoking&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00016926 node30
node30 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Limited Access Phase II Trial Of Capecitabine In Advanced, Persistent Or Recurrent Squamous Cell Carcinoma Of The Cervix</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00016926' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00016926</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Cervical Cancer&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00016224 node31
node31 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase II Trial of Thalidomide in Patients With Ovarian Cancer</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00016224' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00016224</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Ovarian Cancer&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/5015 node32
node32 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>pegvisomant</B></td></tr><tr><td href='https://drugcentral.org/drugcard/5015' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/5015</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021106s036lbl.pdf&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00017459 node33
node33 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>The International Tirazone Triple Trial (i3T): A Phase III, Randomized Efficacy And Safety Study Of The Combination Chemotherapy With Tirapazamine+Cisplatin+Vinorelbine Versus Cisplatin+Vinorelbine In Subjects With Inoperable, Previously Untreated, Non-Small Cell Lung Cancer</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00017459' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00017459</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Lung Cancer&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00018824 node34
node34 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>The Treatment of Late Life Major Depression Complication by Alcohol</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00018824' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00018824</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Alcoholism&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00011986 node35
node35 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase III Randomized Trial Of Paclitaxel And Carboplatin Versus Triplet Or Sequential Doublet Combinations In Patients With Epithelial Ovarian Or Primary Peritoneal Carcinoma</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00011986' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00011986</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Primary Peritoneal Carcinoma&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00018668 node36
node36 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Psychopharmacologic Aspects of Motor Slowing in Schizophrenia</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00018668' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00018668</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Schizophrenia&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00017680 node37
node37 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00017680' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00017680</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Amyloidosis&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00014443 node38
node38 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Pilot Study Of Hycamtin (Topotecan) And Thalomid (Thalidomide) In Patients With Recurrent Malignant Gliomas</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00014443' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00014443</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Brain and Central Nervous System Tumors&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00014183 node39
node39 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase II Study Of ZD1839 (NSC #715055) In Renal Cell Carcinoma Stage IV And Renal Cell Carcinoma Recurrent</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00014183' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00014183</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Kidney Cancer&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D000077143 node40
node40 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D000077143</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D000077143' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D000077143</font></td></tr></table> > ] 
# https://drugcentral.org/drugcard/2337 node41
node41 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>quetiapine</B></td></tr><tr><td href='https://drugcentral.org/drugcard/2337' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/2337</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3188993&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00018642 node42
node42 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Predicting the Optimal Pharmacotherapy for Outpatients With Schizophrenia</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00018642' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00018642</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Schizophrenia&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/1767 node43
node43 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>methylphenidate</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1767' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1767</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL796&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D008774 node44
node44 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D008774</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D008774' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D008774</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015808 node45
node45 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase I Clinical Trial to Establish the Maximum Tolerated Dose of Idebenone in Children, Adolescents, and Adults With Friedreich&#x27;s Ataxia</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015808' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015808</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Friedreich Ataxia&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/5414 node46
node46 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>lonafarnib</B></td></tr><tr><td href='https://drugcentral.org/drugcard/5414' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/5414</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://pubmed.ncbi.nlm.nih.gov/10377218&quot;</td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213969s000lbl.pdf&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015899 node47
node47 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase I Trial Of Escalating Oral Doses Of SCH 66336 In Pediatric Patients With Refractory Or Recurrent Brain Tumors</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015899' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015899</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Brain and Central Nervous System Tumors&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/2351 node48
node48 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>raloxifene</B></td></tr><tr><td href='https://drugcentral.org/drugcard/2351' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/2351</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2820&quot;</td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL81&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/1122 node49
node49 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>exemestane</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1122' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1122</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200374&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00018850 node50
node50 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>5HT3 Antagonism and Auditory Gating in Schizophrenia</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00018850' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00018850</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Schizophrenia&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/2303 node51
node51 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>propranolol</B></td></tr><tr><td href='https://drugcentral.org/drugcard/2303' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/2303</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/016419s029lbl.pdf&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/2373 node52
node52 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>ribavirin</B></td></tr><tr><td href='https://drugcentral.org/drugcard/2373' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/2373</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1643&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015054 node53
node53 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>MPD04961-Methylphendidate Treatment of Cocaine Dependent ADHD Patients</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015054' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015054</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Cocaine-Related Disorders&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00016432 node54
node54 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Randomized Trial Evaluating The Effect Of Exemestane In Clinical Stage T1-3 N0-1 M0 Postmenopausal Breast Cancer Patients Completing At Least Five Years Of Tamoxifen Therapy</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00016432' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00016432</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Breast Cancer&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/4161 node55
node55 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>temsirolimus</B></td></tr><tr><td href='https://drugcentral.org/drugcard/4161' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/4161</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201182&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00016328 node56
node56 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase II Study of CCI-779 in Patients With Recurrent Glioblastoma Multiforme</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00016328' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00016328</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Adult Giant Cell Glioblastoma&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00014404 node57
node57 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase II Double-Blind, Placebo Controlled, Randomized Study Of Celecoxib, A Selective COX-2 Inhibitor, In Oral Premalignant Lesions</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00014404' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00014404</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Head and Neck Cancer&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00019318 node58
node58 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase I Trial of a Four Hour Infusion of Depsipeptide (NSC630176) Given on Days 1 and 5 of a 21 Day Cycle in Patients With Refractory Neoplasms</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00019318' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00019318</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Lymphoma&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00017160 node59
node59 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase II Study of Neoadjuvant Doxorubicin and Ifosfamide, Radiotherapy, and Surgical Resection in Patients With Primary or Recurrent Retroperitoneal Sarcoma</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00017160' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00017160</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Stage III Adult Soft Tissue Sarcoma&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015249 node60
node60 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Prepulse Inhibition of Startle in Cocaine Dependence (Human)</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015249' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015249</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Cocaine-Related Disorders&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00017147 node61
node61 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase III Study of Radiation Therapy (RT) and O6-Benzylguanine (O6-BG) Plus BCNU Versus RT and BCNU Alone for Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00017147' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00017147</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/391 node62
node62 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>bortezomib</B></td></tr><tr><td href='https://drugcentral.org/drugcard/391' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/391</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00019552 node63
node63 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase II Study of MGI-114 in Patients With Recurrent or Persistent Epithelial Ovarian Cancer</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00019552' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00019552</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Fallopian Tube Cancer&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/2616 node64
node64 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>thalidomide</B></td></tr><tr><td href='https://drugcentral.org/drugcard/2616' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/2616</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://pubmed.ncbi.nlm.nih.gov/25043012&quot;</td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://pubmed.ncbi.nlm.nih.gov/26131937&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015990 node65
node65 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase II Study of Thalidomide in the Treatment of Myelodysplastic Syndromes in Adults: A Clinical and Biologic Study</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015990' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015990</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Chronic Myelomonocytic Leukemia&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/1539 node66
node66 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>lamivudine</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1539' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1539</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL141&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00017719 node67
node67 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Randomized Trial of Protease Inhibitor-Including vs. Protease Inhibitor-Sparing Regimens for Women Who Initiate Therapy of HIV Infection During Pregnancy</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00017719' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00017719</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;HIV Infections&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00016965 node68
node68 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase II Trial of Epothilone B Analogue BMS-247550 (NSC #710428) Every 21 Days in Patients With Advanced Pancreas Cancer</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00016965' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00016965</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Pancreatic Cancer&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/2376 node69
node69 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>rifabutin</B></td></tr><tr><td href='https://drugcentral.org/drugcard/2376' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/2376</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL444633&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00019747 node70
node70 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase II Trial of Oral Thalidomide as an Adjuvant Agent Following Metastasectomy in Patients With Recurrent Colorectal Cancer</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00019747' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00019747</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Colorectal Cancer&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/348 node71
node71 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>betamethasone</B></td></tr><tr><td href='https://drugcentral.org/drugcard/348' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/348</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL632&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/1343 node72
node72 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>guanfacine</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1343' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1343</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022037s011lbl.pdf&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/790 node73
node73 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>decitabine</B></td></tr><tr><td href='https://drugcentral.org/drugcard/790' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/790</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201129&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D000077209 node74
node74 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D000077209</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D000077209' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D000077209</font></td></tr></table> > ] 
# https://drugcentral.org/drugcard/1646 node75
node75 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>mecamylamine</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1646' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1646</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267936&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00018174 node76
node76 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00018174' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00018174</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Depression&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/692 node77
node77 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>clofazimine</B></td></tr><tr><td href='https://drugcentral.org/drugcard/692' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/692</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00018044 node78
node78 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Natural History, Genetics, Phenotype, and Treatment of Mycobacterial Infections</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00018044' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00018044</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Mycobacterium Infections&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D017828 node79
node79 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D017828</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D017828' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D017828</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00011999 node80
node80 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase II Early Postoperative Paclitaxel Followed By Paclitaxel And Cisplatin Concurrent With Radiation Therapy For Resected, High Risk Squamous Carcinoma Of The Head And Neck</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00011999' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00011999</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Head and Neck Cancer&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/824 node81
node81 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>dexamethasone</B></td></tr><tr><td href='https://drugcentral.org/drugcard/824' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/824</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D003907 node82
node82 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D003907</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D003907' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D003907</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015106 node83
node83 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>CREST-I: Resperine, Gabapentin, or Lamotrigine vs. Placebo</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015106' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015106</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Cocaine-Related Disorders&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/480 node84
node84 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>capecitabine</B></td></tr><tr><td href='https://drugcentral.org/drugcard/480' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/480</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1773&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D000077205 node85
node85 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D000077205</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D000077205' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D000077205</font></td></tr></table> > ] 
# https://drugcentral.org/drugcard/1416 node86
node86 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>idebenone</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1416' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1416</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00019773 node87
node87 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Pilot Study of Oxaliplatin in Combination With Capecitabine in Adult Cancer Patients</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00019773' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00019773</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Carcinoma of the Appendix&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00018083 node88
node88 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00018083' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00018083</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Tuberculosis&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00016952 node89
node89 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase II Study in Patients With Metastatic Colorectal Carcinoma Previously Treated With Oxaliplatin (OXAL) or a Combination of Irinotecan (CPT-11) and OXAL</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00016952' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00016952</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Colorectal Cancer&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00010413 node90
node90 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00010413' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00010413</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Pemphigus&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00012142 node91
node91 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Randomized, Double-Blind, Placebo-Controlled, Phase II Study Of Intravenous CCI-779 Administered Weekly To Patients With Androgen-Independent Prostate Cancer</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00012142' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00012142</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Prostate Cancer&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/1992 node92
node92 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>ondansetron</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1992' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1992</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/2706 node93
node93 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>topiramate</B></td></tr><tr><td href='https://drugcentral.org/drugcard/2706' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/2706</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/144 node94
node94 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>amantadine</B></td></tr><tr><td href='https://drugcentral.org/drugcard/144' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/144</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL660&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015821 node95
node95 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Pilot Study of Thalidomide as an Inhibitor of Angiogenesis in the Treatment of Myelofibrosis With Myeloid Metaplasia (MMM)</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015821' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015821</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Primary Myelofibrosis&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/588 node96
node96 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>chlorambucil</B></td></tr><tr><td href='https://drugcentral.org/drugcard/588' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/588</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00014170 node97
node97 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase II Study Of ZD1839 (NSC 715055) In Newly Diagnosed Patients With Glioblastoma (Grade 4 Astrocytoma)</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00014170' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00014170</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Adult Giant Cell Glioblastoma&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/812 node98
node98 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>desipramine</B></td></tr><tr><td href='https://drugcentral.org/drugcard/812' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/812</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL72&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00016991 node99
node99 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase II Study of ZD 1839 (NSC 715055) for Patients With First Relapse Glioblastoma Multiforme</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00016991' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00016991</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Brain and Central Nervous System Tumors&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/1483 node100
node100 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>irofulven</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1483' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1483</font></td></tr></table> > ] 
# https://drugcentral.org/drugcard/758 node101
node101 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>cyclophosphamide</B></td></tr><tr><td href='https://drugcentral.org/drugcard/758' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/758</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00017628 node102
node102 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00017628' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00017628</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Multiple Sclerosis&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015210 node103
node103 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Efficacy of Nefazodone in Cocaine Dependent Subjects</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015210' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015210</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Cocaine-Related Disorders&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00012337 node104
node104 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Trial of ZD1839 (Iressa) in Patients With Advanced Renal Cell Carcinoma</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00012337' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00012337</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Kidney Cancer&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/1513 node105
node105 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>itraconazole</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1513' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1513</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22587&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/434 node106
node106 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>buprenorphine</B></td></tr><tr><td href='https://drugcentral.org/drugcard/434' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/434</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511142&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D002047 node107
node107 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D002047</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D002047' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D002047</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015626 node108
node108 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015626' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015626</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Insulin Resistance&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00014144 node109
node109 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Evaluation of ZD1839 (NSC #715055) for Advanced Transitional Cell Carcinoma of the Urothelium, Phase II</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00014144' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00014144</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Bladder Cancer&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/5011 node110
node110 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>aldesleukin</B></td></tr><tr><td href='https://drugcentral.org/drugcard/5011' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/5011</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/103293s5130lbl.pdf&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/1982 node111
node111 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>olanzapine</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1982' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1982</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/1508 node112
node112 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>isotretinoin</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1508' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1508</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL547&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/1563 node113
node113 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>levetiracetam</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1563' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1563</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://pubmed.ncbi.nlm.nih.gov/18500360&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00018902 node114
node114 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Treatment of SSRI-Resistant Depression in Adolescents (TORDIA)</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00018902' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00018902</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Depression&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00018733 node115
node115 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Biological Aspects of Depression and Antidepressant Drugs</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00018733' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00018733</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Depression&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015041 node116
node116 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>PK 0396 - Buprenorphine Dose Escalation Trial</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015041' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015041</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Opioid-Related Disorders&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015223 node117
node117 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Methyphendidate in the Treatment of Cocaine Dependent Patients With Adult ADHD</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015223' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015223</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Cocaine-Related Disorders&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/1311 node118
node118 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>glutamine</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1311' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1311</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00018109 node119
node119 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD)</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00018109' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00018109</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Muscular Dystrophy, Duchenne&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00018200 node120
node120 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Efficacy of Antidepressants in Chronic Back Pain</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00018200' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00018200</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Back Pain&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/1678 node121
node121 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>melphalan</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1678' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1678</font></td></tr></table> > ] 
# https://drugcentral.org/drugcard/1765 node122
node122 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>naltrexone</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1765' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1765</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D017374 node123
node123 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D017374</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D017374' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D017374</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015652 node124
node124 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Pilot Study of Low Dose Interleukin-2 (IL-2) With the Addition of Pegylated Interferon (PEG-IFN Alfa-2b) and Ribavirin (RBV) for the Treatment of Hepatitis C Infection in Subjects With HIV Coinfection</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015652' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015652</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;HIV Infections&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00013598 node125
node125 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Treatment of Nonalcoholic Steatohepatitis With Pioglitazone</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00013598' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00013598</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Fatty Liver&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00019760 node126
node126 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase II Study of Isolated Hepatic Perfusion With Melphalan Followed By Postoperative Hepatic Arterial Chemotherapy in Patients With Unresectable Colorectal Cancer Metastatic to the Liver</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00019760' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00019760</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Recurrent Colon Cancer&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00014638 node127
node127 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Open Label, Multicenter Trial Of Femera (Letrozole) 2.5 mg As First-line Therapy In Postmenopausal Women With Metastatic Breast Cancer Relapsing Following Adjuvant Tamoxifen Therapy</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00014638' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00014638</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Breast Cancer&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/2436 node128
node128 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>sertraline</B></td></tr><tr><td href='https://drugcentral.org/drugcard/2436' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/2436</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL809&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015132 node129
node129 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>CREST-II: Tiagabine, Sertraline, or Donepezil vs. Unmatched Placebo</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015132' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015132</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Cocaine-Related Disorders&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00017927 node130
node130 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00017927' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00017927</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;McCune Albright Syndrome&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00011960 node131
node131 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Randomized Phase II Comparison Of Two Cisplatin-Paclitaxel Containing Chemoradiation Regimens In Resected Gastric Cancers</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00011960' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00011960</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Esophageal Cancer&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00019968 node132
node132 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase II Randomized Study of Isolated Limb Perfusion Using Melphalan With or Without Tumor Necrosis Factor in Patients With Unresectable High Grade Soft Tissue Sarcomas of the Extremity</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00019968' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00019968</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Stage IVB Adult Soft Tissue Sarcoma&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00019513 node133
node133 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase I Study of Weekly Gemcitabine in Combination With Infusional 5-Fluorouracil and Oral Calcium Leucovorin in Adult Cancer Patients</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00019513' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00019513</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Colorectal Cancer&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D005973 node134
node134 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D005973</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D005973' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D005973</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00011778 node135
node135 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase I Study of Concomitant Therapy With Proteasome Inhibitor PS-341 and Radiation in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00011778' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00011778</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Squamous Cell Carcinoma&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00016393 node136
node136 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase II Trial of Epothilone B Analogue BMS-247550 (NSC #710428) (IND 59699) Administered Every 21 Days in Patients With Hormone Refractory Prostate Cancer</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00016393' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00016393</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Prostate Cancer&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00012467 node137
node137 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Phase II Study of the Safety and Antifungal Activity of Subcutaneous Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) in Conjunction With Standard Therapy in Patients With Acute Cryptococcal Meningitis</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00012467' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00012467</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Meningitis, Cryptococcal&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015002 node138
node138 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Randomized Placebo-Controlled Trial of Antenatal Corticosteroid Regimens</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015002' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015002</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Complications, Pregnancy&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00014313 node139
node139 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase II Study to Evaluate the Role of Weekly Cisplatin With Oral Etoposide in Ewing&#x27;s Sarcoma and Primitive Neuroectodermal Tumor (PNET) With Bone and/or Bone Marrow Metatstatic Disease</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00014313' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00014313</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Sarcoma&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/770 node140
node140 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>cytarabine</B></td></tr><tr><td href='https://drugcentral.org/drugcard/770' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/770</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL803&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00017563 node141
node141 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase I/II Study of Neoadjuvant Weekly Docetaxel and Mitoxantrone Prior to Prostatectomy in Patients With High Risk Localized Prostate Cancer</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00017563' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00017563</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Prostate Cancer&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/2846 node142
node142 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>voriconazole</B></td></tr><tr><td href='https://drugcentral.org/drugcard/2846' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/2846</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL638&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/1971 node143
node143 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>nortriptyline</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1971' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1971</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://pubmed.ncbi.nlm.nih.gov/17071817&quot;</td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL445&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00016016 node144
node144 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase I/II Study of Flavopiridol (NSC 649890, IND 46,211) in Timed Sequential Combination With Cytosine Arabinoside (Ara-C) and Mitoxantrone for Adults With Poor-Risk Acute Leukemias</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00016016' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00016016</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Recurrent Adult Acute Lymphoblastic Leukemia&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00012025 node145
node145 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase II Trial Of Fulvestrant (Faslodex) In Women With Metastatic Breast Cancer And Failure on Aromatase Inhibitor Therapy</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00012025' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00012025</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Breast Cancer&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00011765 node146
node146 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>The Effect of Fluoxetine on Measures of Domestic Violence</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00011765' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00011765</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Domestic Violence&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D000077287 node147
node147 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D000077287</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D000077287' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D000077287</font></td></tr></table> > ] 
# https://drugcentral.org/drugcard/2801 node148
node148 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>valganciclovir</B></td></tr><tr><td href='https://drugcentral.org/drugcard/2801' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/2801</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL252321&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00010062 node149
node149 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Study Of Post-Operative Concomitant Radio-Chemotherapy With A Continuous Infusion Of Flourouracil For Adjuvant Treatment Of Resected Pancreatic Cancer</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00010062' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00010062</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Pancreatic Cancer&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00010387 node150
node150 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00010387' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00010387</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Anemia, Hemolytic, Autoimmune&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015067 node151
node151 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Cocaine-Methylphendidate Interaction Study</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015067' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015067</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Cocaine-Related Disorders&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00010140 node152
node152 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Multicenter Randomized Trial of Sequential Epirubicin and Docetaxel Versus Epirubicin in Node Positive Postmenopausal Breast Cancer Patients</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00010140' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00010140</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Breast Cancer&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00014196 node153
node153 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase II Trial of Concurrent Cisplatin/Docetaxel and Radiotherapy Followed by Consolidation Docetaxel in Stage IIIB Non-Small Cell Lung Cancer</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00014196' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00014196</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Lung Cancer&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D000077236 node154
node154 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D000077236</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D000077236' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D000077236</font></td></tr></table> > ] 
# https://drugcentral.org/drugcard/438 node155
node155 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>busulfan</B></td></tr><tr><td href='https://drugcentral.org/drugcard/438' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/438</font></td></tr></table> > ] 
# https://drugcentral.org/drugcard/639 node156
node156 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>cidofovir</B></td></tr><tr><td href='https://drugcentral.org/drugcard/639' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/639</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL152&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00016302 node157
node157 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>The Use of Modified BFM +/- Compound 506U78 (Nelarabine) (NSC# 686673, IND #52611) in an Intensive Chemotherapy Regimen for the Treatment of T-Cell Leukemia</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00016302' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00016302</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;T-cell Childhood Acute Lymphoblastic Leukemia&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00018161 node158
node158 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Combined Pharmacologic/Behavioral Treatment for Smoking Cessation</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00018161' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00018161</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Smoking&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00014209 node159
node159 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase II Study Of Gemcitabine, Dexamethasone, And Cisplatin (GDP) In Patients With Either Hodgkin&#x27;s Disease Or Aggressive Histology Non-Hodgkin&#x27;s Lymphoma Which Is Relapsed Or Refractory</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00014209' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00014209</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Lymphoma&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00018863 node160
node160 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Methylphenidate Efficacy and Safety in ADHD Preschoolers</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00018863' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00018863</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Attention Deficit Disorder With Hyperactivity&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D016316 node161
node161 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D016316</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D016316' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D016316</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00017784 node162
node162 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Open-Label Safety Study of Valganciclovir in Patients With CMV Retinitis and AIDS Who Have Complications Due to IV Treatment</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00017784' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00017784</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Cytomegalovirus Retinitis&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/1890 node163
node163 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>nefazodone</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1890' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1890</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL623&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/2113 node164
node164 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>perphenazine</B></td></tr><tr><td href='https://drugcentral.org/drugcard/2113' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/2113</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL567&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D000077404 node165
node165 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D000077404</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D000077404' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D000077404</font></td></tr></table> > ] 
# https://drugcentral.org/drugcard/1556 node166
node166 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>letrozole</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1556' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1556</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1444&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00010400 node167
node167 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00010400' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00010400</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Systemic Lupus Erythematosus&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00012090 node168
node168 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase II Trial Of Oral Bicalutamide With Subcutaneous Goserelin In Patients With Epithelial Ovarian, Fallopian Tube, Or Peritoneal Carcinoma In Second Or Greater Remission</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00012090' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00012090</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Fallopian Tube Cancer&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00014469 node169
node169 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase II Trial of IV Busulfan (Busulfex) and Melphalan as a Preparatory Regimen Prior to Allogeneic Bone Marrow Transplantation for the Treatment of Advanced and High Risk Hematologic Malignancies</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00014469' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00014469</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Graft Versus Host Disease&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/1517 node170
node170 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>ixabepilone</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1517' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1517</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://pubmed.ncbi.nlm.nih.gov/19010832&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00019539 node171
node171 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase II Randomized Study of Monoclonal Antibody VEGF in Patients With Unresectable Advanced Renal Cell Cancer</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00019539' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00019539</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Stage IV Renal Cell Cancer&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00018291 node172
node172 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Specific Interventions for Agitation in Alzheimer&#x27;s Disease</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00018291' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00018291</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Alzheimer&#x27;s Disease&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015080 node173
node173 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Naltrexone in Treatment of Cocaine Dependence</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015080' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015080</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Cocaine-Related Disorders&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00010075 node174
node174 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Study Of The Survival Without Degradation To The Quality Of Life During Chemotherapy For Metastatic Breast Cancer In Women</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00010075' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00010075</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Breast Cancer&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/1209 node175
node175 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>fluoxetine</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1209' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1209</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00014001 node176
node176 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Comparative Effectiveness of Antipsychotic Medications in Patients With Schizophrenia (CATIE Schizophrenia Trial)</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00014001' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00014001</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Schizophrenia&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D019259 node177
node177 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D019259</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D019259' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D019259</font></td></tr></table> > ] 
# https://drugcentral.org/drugcard/1184 node178
node178 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>floxuridine</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1184' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1184</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL917&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/1725 node179
node179 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>metformin</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1725' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1725</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1703&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00014729 node180
node180 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00014729' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00014729</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Epidermolysis Bullosa&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/512 node181
node181 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>carmustine</B></td></tr><tr><td href='https://drugcentral.org/drugcard/512' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/512</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL513&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/1540 node182
node182 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>lamotrigine</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1540' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1540</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D000077154 node183
node183 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D000077154</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D000077154' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D000077154</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00016874 node184
node184 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase I Study Of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine) In Combination With Cisplatin And Paclitaxel In Patients With Advanced And Metastatic Cancer</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00016874' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00016874</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Unspecified Adult Solid Tumor, Protocol Specific&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/568 node185
node185 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>celecoxib</B></td></tr><tr><td href='https://drugcentral.org/drugcard/568' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/568</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00016081 node186
node186 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Randomized Phase III Study To Evaluate The Safety And Efficacy Or Ribavirin Inhaled Solution In Preventing Progression Of Upper Respiratory Tract Respiratory Syncytial Virus (RSV) Infection To RSV Pneumonia In Blood And Bone Marrow Transplant (BMT) Recipients</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00016081' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00016081</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Infection&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00017199 node187
node187 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase II Study of PS-341 in Metastatic Neuroendocrine Tumors</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00017199' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00017199</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Gastrointestinal Carcinoid Tumor&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00010153 node188
node188 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Double-Blind Phase III Clinical Trial to Compare the Effects of a Pre-Operatively Administered Single Dose of &quot;Faslodex&quot; (Long-Acting ICI 182.780) With Placebo on Tumor Recurrence in Pre- and Postmenopausal Women Treated for Operable First Primary Breast Cancer</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00010153' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00010153</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Breast Cancer&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00019123 node189
node189 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A PHASE II STUDY OF ORAL THALIDOMIDE FOR PATIENTS WITH HIV INFECTION AND KAPOSI&#x27;S SARCOMA</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00019123' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00019123</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Sarcoma&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D015474 node190
node190 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D015474</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D015474' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D015474</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00011804 node191
node191 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Topiramate in the Treatment of Sciatica</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00011804' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00011804</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Sciatica&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015301 node192
node192 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Methylphenidate Raclopride PET Test</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015301' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015301</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Cocaine-Related Disorders&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D016642 node193
node193 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D016642</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D016642' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D016642</font></td></tr></table> > ] 
# https://drugcentral.org/drugcard/2253 node194
node194 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>prednisone</B></td></tr><tr><td href='https://drugcentral.org/drugcard/2253' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/2253</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL635&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00018603 node195
node195 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Guanfacine for the Treatment of PTSD</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00018603' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00018603</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Post-Traumatic Stress Disorder&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00016380 node196
node196 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Randomized Phase III Double-Blind Study Of Ondansetron And Dexamethasone Versus Ondansetron And Placebo In The Prophylaxis Of Radiation-Induced Emesis</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00016380' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00016380</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Cancer&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/1255 node197
node197 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>fulvestrant</B></td></tr><tr><td href='https://drugcentral.org/drugcard/1255' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/1255</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1358&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00019825 node198
node198 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase I Study of Decitabine Mediated Induction of Tumor Antigen and Tumor Suppressor Gene Expression in Lung Cancer Patients</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00019825' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00019825</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Esophageal Cancer&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D017294 node199
node199 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D017294</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D017294' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D017294</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015665 node200
node200 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Open-Label, Non-Comparative Protocol for the Emergency Use of Voriconazole in Patients With Life Threatening, Invasive Mycoses Who Are Failing on Currently Available Antifungal Agents</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015665' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015665</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Mycoses&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00016068 node201
node201 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase III Multicenter Study Of Valganciclovir For The Prevention Of Late Cytomegalovirus Infection After Allogeneic Hematopoietic Stem Cell Transplantation</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00016068' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00016068</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Infection&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015548 node202
node202 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Comparative Effectiveness of Antipsychotic Medications in Patients With Alzheimer&#x27;s Disease (CATIE Alzheimer&#x27;s Disease Trial)</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015548' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015548</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Alzheimer&#x27;s Disease&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D000077152 node203
node203 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D000077152</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D000077152' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D000077152</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00013897 node204
node204 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase III Study Comparing the Antiviral Efficacy and Safety of BMS-232632 With Efavirenz; Each in Combination With Fixed Dose Zidovudine-Lamivudine</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00013897' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00013897</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;HIV Infections&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00012038 node205
node205 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase I/II Trial Of MGI114 For Treatment Of Patients With Recurrent Malignant Gliomas</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00012038' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00012038</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Brain and Central Nervous System Tumors&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D017964 node206
node206 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D017964</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D017964' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D017964</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D002330 node207
node207 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D002330</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D002330' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D002330</font></td></tr></table> > ] 
# https://drugcentral.org/drugcard/2389 node208
node208 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>risperidone</B></td></tr><tr><td href='https://drugcentral.org/drugcard/2389' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/2389</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D000077267 node209
node209 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D000077267</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D000077267' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D000077267</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00017056 node210
node210 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Phase II Study Of Epothilone Analog BMS-247550 In Patients With Metastatic Gastric Adenocarcinoma Previously Treated With A Fluoropyrimidine And/Or Platinum</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00017056' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00017056</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Esophageal Cancer&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D000547 node211
node211 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D000547</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D000547' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D000547</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D000068579 node212
node212 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D000068579</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D000068579' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D000068579</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00015769 node213
node213 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Pilot Evaluation of Levetiracetam (Keppra (Registered Trademark)) in Bipolar Illness</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00015769' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00015769</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Bipolar Disorder&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00017108 node214
node214 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Low Dose Chlorambucil Maintenance Vs. No Treatment Following High-Dose Chlorambucil Induction In Patients With Advanced B-Chronic Lymphocytic Leukemia. A Randomized Phase III Study Of The EORTC LG (CLL-3)</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00017108' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00017108</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Leukemia&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D003561 node215
node215 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D003561</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D003561' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D003561</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D000077156 node216
node216 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D000077156</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D000077156' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D000077156</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D012254 node217
node217 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D012254</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D012254' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D012254</font></td></tr></table> > ] 
# https://drugcentral.org/drugcard/2044 node218
node218 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>paclitaxel</B></td></tr><tr><td href='https://drugcentral.org/drugcard/2044' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/2044</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://pubmed.ncbi.nlm.nih.gov/11309480&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/254 node219
node219 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>atazanavir</B></td></tr><tr><td href='https://drugcentral.org/drugcard/254' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/254</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1163&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00019240 node220
node220 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>PHASE II PROTOCOL WITH LABORATORY CORRELATES OF 1-[(S)-3-HYDROXY-2-(PHOSPHOMETHOXY)PROPYL]CYTOSINE DIHYDRATE(CIDOFOVIR) IN PATIENTS WITH KAPOSI&#x27;S SARCOMA (KS)</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00019240' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00019240</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Sarcoma&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D000077606 node221
node221 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D000077606</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D000077606' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D000077606</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00019500 node222
node222 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Randomized Phase II Trial of Two Doses of Raloxifene in Pre-Menopausal Women at High Risk For Developing Invasive Breast Cancer</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00019500' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00019500</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Breast Cancer&quot;</td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00014352 node223
node223 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Phase II Trial Of Sequential Estramustine/Paclitaxel Followed By Doxorubicin/Ketoconazole In Patients With Androgen-Independent Prostate Cancer</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00014352' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00014352</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Prostate Cancer&quot;</td></tr></table> > ] 
# https://drugcentral.org/drugcard/367 node224
node224 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>bicalutamide</B></td></tr><tr><td href='https://drugcentral.org/drugcard/367' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://drugcentral.org/drugcard/367</font></td></tr><tr><td align='left'>schema:url</td><td align='left'>&quot;https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL409&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D002945 node225
node225 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D002945</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D002945' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D002945</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D008464 node226
node226 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D008464</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D008464' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D008464</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D003891 node227
node227 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D003891</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D003891' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D003891</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00018382 node228
node228 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Insulin, Neurogenetics and Memory in Alzheimer&#x27;s Disease: A Novel Therapeutic Approach</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00018382' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00018382</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Alzheimer Disease&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D003520 node229
node229 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D003520</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D003520' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D003520</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D000068258 node230
node230 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D000068258</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D000068258' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D000068258</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00014586 node231
node231 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>Randomized Phase III Step-Up Study On Initial Antiandrogen Monotherapy In Comparison With Watchful Waiting In Asymptomatic T1-3 Any G (Any Gleason) NO or Nx M0 Prostate Cancer Patients Without Local Treatment With Curative Intent</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00014586' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00014586</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Prostate Cancer&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D000077289 node232
node232 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D000077289</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D000077289' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D000077289</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D000069287 node233
node233 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D000069287</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D000069287' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D000069287</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D008558 node234
node234 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D008558</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D008558' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D008558</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D011241 node235
node235 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D011241</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D011241' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D011241</font></td></tr></table> > ] 
# https://clinicaltrials.gov/ct2/show/NCT00012584 node236
node236 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>A Treatment Study of Youth With Comorbid Attention Deficit Hyperactivity Disorder (ADHD) and Anxiety Disorders</B></td></tr><tr><td href='https://clinicaltrials.gov/ct2/show/NCT00012584' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://clinicaltrials.gov/ct2/show/NCT00012584</font></td></tr><tr><td align='left'>schema:MedicalCondition</td><td align='left'>&quot;Attention Deficit Hyperactivity Disorder&quot;</td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D002699 node237
node237 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D002699</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D002699' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D002699</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D005473 node238
node238 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D005473</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D005473' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D005473</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D002991 node239
node239 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D002991</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D002991' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D002991</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D018967 node240
node240 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D018967</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D018967' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D018967</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D009271 node241
node241 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D009271</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D009271' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D009271</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D009661 node242
node242 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D009661</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D009661' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D009661</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D013792 node243
node243 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D013792</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D013792' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D013792</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D010546 node244
node244 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D010546</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D010546' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D010546</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D002066 node245
node245 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D002066</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D002066' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D002066</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D065819 node246
node246 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D065819</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D065819' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D065819</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D008687 node247
node247 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D008687</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D008687' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D008687</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D000069286 node248
node248 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D000069286</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D000069286' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D000069286</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D000077213 node249
node249 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D000077213</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D000077213' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D000077213</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D015774 node250
node250 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D015774</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D015774' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D015774</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D005467 node251
node251 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D005467</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D005467' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D005467</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D011433 node252
node252 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D011433</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D011433' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D011433</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D001623 node253
node253 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D001623</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D001623' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D001623</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D005472 node254
node254 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D005472</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D005472' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D005472</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D000077562 node255
node255 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D000077562</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D000077562' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D000077562</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D020280 node256
node256 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D020280</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D020280' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D020280</font></td></tr></table> > ] 
# https://www.ncbi.nlm.nih.gov/mesh/?term=D017239 node257
node257 [ shape=none, color=black label=< <table color='#666666' cellborder='0' cellspacing='0' border='1'><tr><td colspan='2' bgcolor='grey'><B>D017239</B></td></tr><tr><td href='https://www.ncbi.nlm.nih.gov/mesh/?term=D017239' bgcolor='#eeeeee' colspan='2'><font point-size='10' color='#6666ff'>https://www.ncbi.nlm.nih.gov/mesh/?term=D017239</font></td></tr></table> > ] 
}
